These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24138600)

  • 1. Perforating elastic fibers ('elastic fiber trapping') in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia.
    Shah K; Kazlouskaya V; Lal K; Molina D; Elston DM
    J Cutan Pathol; 2014 Feb; 41(2):108-12. PubMed ID: 24138600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: a pilot study.
    Bowen AR; Burt L; Boucher K; Tristani-Firouzi P; Florell SR
    J Cutan Pathol; 2012 Feb; 39(2):243-50. PubMed ID: 22236162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia.
    Lin JH; Lee JY
    J Cutan Pathol; 2004 Jul; 31(6):458-61. PubMed ID: 15186435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudocarcinomatous hyperplasia in anaplastic large cell lymphoma, a mimicker of poorly differentiated squamous cell carcinoma: report of a case and review of the literature.
    Price A; Miller JH; Junkins-Hopkins JM
    J Cutan Pathol; 2015 Nov; 42(11):863-9. PubMed ID: 26040921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of laminin-5 γ2 chain in cutaneous pseudocarcinomatous hyperplasia.
    Dos Santos AM; Carneiro FP; Queiroz AJ; Damasceno EA; de Castro TM; de Amorim RF; Takano GH; Junqueira MI; de Magalhães AV
    J Cutan Pathol; 2011 Nov; 38(11):871-5. PubMed ID: 21955313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma.
    Ohashi A; Ishizaki M; Kawana S; Fukuda Y
    Pathol Int; 2004 Aug; 54(8):585-94. PubMed ID: 15260849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
    King DF; Barr RJ
    J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
    Misago N; Inoue T; Koba S; Narisawa Y
    J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
    Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
    J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
    Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudocarcinomatous Hyperplasia, Squamous Cell Carcinoma, and Keratoacanthoma Associated to Lymphomas of the Skin and External Mucous Membranes: A Case Report and Literature Review.
    Jeunon T; Assoni A; Verdolin A
    Am J Dermatopathol; 2020 Sep; 42(9):662-672. PubMed ID: 31833842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers.
    Slater M; Barden JA
    Histopathology; 2005 Aug; 47(2):170-8. PubMed ID: 16045778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
    Vasiljević N; Andersson K; Bjelkenkrantz K; Kjellström C; Månsson H; Nilsson E; Landberg G; Dillner J; Forslund O
    Int J Cancer; 2009 May; 124(10):2361-6. PubMed ID: 19165861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
    Jacobs MS; Persons DL; Fraga GR
    J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le(Y) expression.
    Tsuji T
    J Cutan Pathol; 1997 Aug; 24(7):409-15. PubMed ID: 9274958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
    Takai T; Misago N; Murata Y
    J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.